GHGuangda He

Guangda He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guangda He has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Jianlan Cui

    National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China

    2 shared publications
  • Liang Chen

    State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    2 shared publications
  • Xiaoyan Zhang

    2 shared publications
  • Yang Yang

    2 shared publications
  • Aoxi Tian

    National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People’s Republic of China

    1 shared publication
  • Bowang Chen

    National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Evaluating Somatic Mutational Contamination in Large-Scale Germline Genomic Studies

    by Xiangwen Ji, Xueke Bai, Guangda He, Kai Yan, Edwin Wang, Yi-Da Tang, Liang Chen, Qinghua Cui

    Large-scale genomic initiatives like the UK Biobank have revolutionized our understanding of human disease. These studies typically assume that blood-derived DNA faithfully reflects an individual’s germline genome. However, this assumption is challenged by somatic mutations arising from processes like clonal hematopoiesis. Although standard bioinformatics pipelines employ variant allele frequency (VAF)-based filtering to mitigate such contamination, the efficacy of these approaches requires systematic evaluation. By systematically analyzing germline genome data from large cohorts through applications of mutational signatures, we revealed critical limitations in current filtering methodologies. We found that the mutational spectrum of rare “germline” variants is highly similar to that of somatic mutations. Furthermore, we uncovered that these variants show significant associations with phenotypes such as age, sex, and smoking status, established drivers of somatic mutagenesis. Notably, our multivariable regression models estimated that these somatic artifacts contribute to a substantial excess burden, such as 4.73 mutations per megabase (mut/Mb) in males compared to females, a magnitude exceeding the mutation burden of many cancers. Although the precise absolute size of this contamination may vary depending on specific pathologies and individual environmental exposures, this persistent somatic contamination introduces substantial confounder effects, posing a risk of spurious associations and reverse causality in genetic studies. Our work underscores the urgent reconsideration of two fundamental aspects of genomic research: (1) refinement of variant filtering strategies to better distinguish true germline variants from somatic contaminants, and (2) incorporation of somatic mutagenesis factors as essential covariates in study design. Our findings provide basic guidance for improving the accuracy and interpretability of large-scale genomic studies.

  • Open Access

    Long-term exposure to ozone and incidence of lung cancer in China: data based on a national population cohort (ChinaHEART)

    by Yi Wu, Chunqi Wang, Chunxiao Xu, Siming Wang, Rongshou Zheng, Chunying Lin, Xiaoyan Zhang, Bowang Chen, Yang Yang, Wei Li, et al.


  • Open Access

    Long‐Term Cumulative High‐Sensitivity C‐Reactive Protein and Mortality Among Patients With Acute Heart Failure

    by Lihua Zhang, Guangda He, Xiqian Huo, Aoxi Tian, Runqing Ji, Boxuan Pu, Yue Peng

    Background: Elevated hsCRP (high‐sensitivity C‐reactive protein) level is associated with worse prognosis among patients hospitalized for heart failure. However, the prognostic value of the long‐term cumulative hsCRP remains unknown. Methods and Results: We consecutively enrolled patients hospitalized for heart failure and collected their hsCRP data at admission and 1 and 12 months after discharge. Long‐term cumulative hsCRP was evaluated using 2 approaches, cumulative hsCRP level quartiles and cumulative times of high hsCRP levels. Patients were classified into 4 groups by cumulative hsCRP level quartiles and cumulative times of high hsCRP levels (0‐ to 3‐times: number of times that hsCRP levels were higher than cutoff values at admission or 1 or 12 months), respectively. Multivariable Cox models were used to assess the association of mortality with cumulative hsCRP. A total of 1281 patients were included; the median age was 64 (interquartile range, 54–73) years, and 35.4% were women. Over a 4.8‐year (interquartile range, 4.2–5.1) follow‐up, 374 (29.2%) patients died. Elevated long‐term cumulative hsCRP level was related to higher mortality. Specifically, taking the quartile 1 as the reference, the hazard ratios (HRs) were 1.29 (95% CI, 0.92–1.81) for quartile 2, 1.62 (95% CI, 1.16–2.25) for quartile 3, and 2.38 (95% CI, 1.75–3.23) for quartile 4. Similarly, compared with the patients with 0‐times (hsCRP level lower than the cutoff values in all 3 time points) of high hsCRP level, the HRs were 1.36 for 1‐time (hsCRP level higher than the cutoff value in one of the 3 time points) (95% CI, 0.92–2.01), 1.95 for 2‐times (hsCRP levels higher than the cutoff values in 2 of the 3 time points) (95% CI, 1.34–2.82), and 2.80 for 3‐times (hsCRP levels higher than the cutoff values in the 3 time points) (95% CI, 1.97–4.00). Conclusions: Increasing long‐term cumulative hsCRP level was associated with worse outcomes in patients hospitalized for acute heart failure. Repeated hsCRP measurements could assist physicians in identifying patients with a high risk of death. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT 02878811.